NUSTAT XR Trademark

Trademark Overview

On Monday, November 21, 2022, a trademark application was filed for NUSTAT XR with the United States Patent and Trademark Office. The USPTO has given the NUSTAT XR trademark a serial number of 97685650. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, March 3, 2026. This trademark is owned by Beeken Biomedical LLC. The NUSTAT XR trademark is filed in the Pharmaceutical Products category with the following description:

Hemostatic dressings to control bleeding; medical and surgical dressings
nustat xr

General Information

Serial Number97685650
Word MarkNUSTAT XR
Filing DateMonday, November 21, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

NOT AVAILABLE"XR"
Goods and ServicesHemostatic dressings to control bleeding; medical and surgical dressings

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code005
First Use Anywhere DateTuesday, July 15, 2025
First Use In Commerce DateTuesday, July 15, 2025

Trademark Owner History

Party NameBeeken Biomedical LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNewton, MA 02459
US
Party NameBeeken Biomedical LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressStoughton, MA 02072
US

Trademark Events

Event DateEvent Description
Thursday, November 24, 2022NEW APPLICATION ENTERED
Monday, December 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 2, 2023ASSIGNED TO EXAMINER
Saturday, September 9, 2023NON-FINAL ACTION WRITTEN
Saturday, September 9, 2023NON-FINAL ACTION E-MAILED
Saturday, September 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 7, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, December 7, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, December 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024SOU EXTENSION 1 FILED
Thursday, September 12, 2024SOU EXTENSION 1 GRANTED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 27, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 4, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025SOU EXTENSION 2 FILED
Tuesday, March 4, 2025SOU EXTENSION 2 GRANTED
Wednesday, March 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 28, 2025TEAS STATEMENT OF USE RECEIVED
Sunday, February 1, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 28, 2025USE AMENDMENT FILED
Sunday, February 1, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 3, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 3, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

nustat dressings surgical medical control hemostatic bleeding